Within pT2–pT4 carcinomas, high AR immunostaining was associated with GATA3 (p < 0.0001) and CK20 (p < 0.0001) positivity, p63 expression loss (p = 0.0013), and low PD-L1 expression in cancer cells (p < 0.0001). Here, AR is linked to carcinoma.